Sinopharm
1099.HK
#1835
Rank
NZ$15.58 B
Marketcap
$4.99
Share price
1.15%
Change (1 day)
25.40%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Sinopharm (1099.HK) - P/B ratio

P/B ratio as of December 2024 : 0.5182

According to Sinopharm's latest financial reports the company has a price-to-book ratio of 0.110171.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Sinopharm - P/B ratio (from 2009 to 2023)

P/B ratio by year

Year P/B ratio Change
2023-12-310.4801-3.56%
2022-12-310.497814.7%
2021-12-310.4340-17.03%
2020-12-310.5231-46.93%
2019-12-310.9856-21.62%
2018-12-311.26-6.38%
2017-12-311.34-24.43%
2016-12-311.780.98%
2015-12-311.765.35%
2014-12-311.677.2%
2013-12-311.56-23.67%
2012-12-312.0414.85%
2011-12-311.78-49.81%
2010-12-313.54-9.61%
2009-12-313.92
2008-12-31N/A